Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Gamida Cell Ltd
GMDAQ
Healthcare
Biotechnology
Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and...
potency. The following are the Company's clinical pipeline products: Omidubicel dedicated to hematologic malignancies and severe aplastic anemia; GDA-201 dedicated for treatment of non-Hodgkin Lymphoma; GDA-301, GDA-401, GDA-501 dedicated to treatment of solid tumors, GDA-601 dedicated to multiple myeloma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:GMDAQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(86)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 29, 2024 11:30am
Gamida Cell Actively Pursuing Strategic Alternatives
Just In: $GMDA Gamida Cell Actively Pursuing Strategic AlternativesBOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd . (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 15, 2023 4:08pm
New Press Release - Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
Company reports positive feedback and continued progress on transplant center onboarding and payer coverage around launch of Omisirge® (omidubicel-onlv), a new cell therapy for allogeneic stem cell transplant approved April 17 by the FDACompany successfully completed public offering, raising...
read article.
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 11, 2023 5:20pm
New Press Release - Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to review its first quarter 2023 financial results and provide an...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 19, 2023 9:18am
GMDA.....Surprise surprise....A P.O curveball
What else eh ? Any links to the Conv Deb.....I wonder Gotta churn it ...to burn it Everyone's been had .....again !!!!!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 19, 2023 8:15am
New Press Release - Gamida Cell Announces Pricing of $23 Million Public Offering of Securities
Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the pricing of an underwritten public offering of 17,500,000 ordinary shares and accompanying warrants to purchase 17,500,000 ordinary shares at a public offering price of $1...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 18, 2023 7:16pm
New Press Release - Gamida Cell Announces Launch of Public Offering of Securities
Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants to purchase its ordinary shares. In addition, Gamida Cell expects to grant the...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 1:23pm
GMDA ....called that PB like a Champ
1 cent off then the rally to N.H.O.D The Trend is your friend ; ) Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 12:44pm
GMDA..... Nice action on a Co that just had FDA approval
As mentioned ....just reached the H.O.D of $1.80....I'm thinking a PB to support at $1.67.... if it holds...all is good....if not....~ $1.58 would be the next support....that support is crucial
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 12:20pm
GMDA ..... Well my target was reached ....$1.72 and broken
New target is ............$1.87...after a PB Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 12:16pm
GMDA..... New N.H.O.D
How sweeeeeetttttt it is !!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Cha Ching !!!!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 11:45am
GMDA ..... N.H.O.D
Just an observation
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Apr 18, 2023 10:50am
RE:GMDA.... I betcha this breaks to N.H.O.D
My chart tells me there is res at $1.72 A break of that would be meaningful
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 10:49am
GMDA.... I betcha this breaks to N.H.O.D
FDA approval.....why not !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 10:48am
GMDA....dang should coulda ...didn't
buy the dip Back to the drawing board
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 18, 2023 10:26am
GMDA ..... $1.58 res......support at $1.35
No position
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results